Bengaluru, India

Kedamath Nanjund Sastry


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kedamath Nanjund Sastry: Innovator in Biotechnology

Introduction

Kedamath Nanjund Sastry is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression and genetic engineering. With a total of two patents to his name, his work has the potential to impact various applications in medicine and agriculture.

Latest Patents

Kedamath Nanjund Sastry's latest patents include a process for the identification and isolation of sorbitol dehydrogenase promoter. This process relates to the expression of heterologous proteins under the control of the sorbitol dehydrogenase promoter. His second patent involves a process for obtaining a fully folded two-chain insulin glargine that requires no further processing to become functionally active. This innovative approach reveals a surprising effect of overexpression of Kex2p intracellularly under the control of the inducible FLD1 promoter, allowing for the production of two-chain functional glargine that is secreted directly into the medium.

Career Highlights

Kedamath Nanjund Sastry is currently employed at Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to explore and develop groundbreaking biotechnological solutions. His expertise in protein engineering and genetic manipulation has positioned him as a valuable asset in the field.

Collaborations

Some of his notable coworkers include Nagaraj Govindappa and Suma Sreenivas. Their collaborative efforts contribute to the innovative environment at Biocon Limited, fostering advancements in biotechnology.

Conclusion

Kedamath Nanjund Sastry is a distinguished inventor whose work in biotechnology has led to significant advancements in protein expression and insulin production. His contributions continue to shape the future of biopharmaceuticals and genetic engineering.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…